Making Compliance the New Routine

The SimpliPro Colon™ test is a blood test that aids in the assessment of your patient’s colorectal health and fits seamlessly into your routine workups. This laboratory service is designed to enable better compliance for diagnostic colonoscopy in patients presenting with symptoms associated with colorectal cancer.
Request a Test

Learn About At-Home Blood Draws

use this snippet for dark background arrows

Test Performance

A Simple Blood Test

The SimpliPro Colon test collection is administered like other blood tests, fitting ideally into your practice’s routine

Learn More

To our knowledge, the SimpliPro Colon test is the only blood test that assesses risk for advanced adenoma in elevated-risk patients. The SimpliPro Colon test has not been validated in an asymptomatic screening population for colorectal cancer.

Test Technology

The SimpliPro Colon test is a protein-based blood test that was developed using the proprietary mass spectrometry platform and test algorithm designed by Applied Proteomics, Inc.

11_proteins_icon
light background arrow

Clinical Data

The SimpliPro Colon test was developed across multiple studies that included 1,605 patients.1
use this snippet for dark background arrows

Make Patient Compliance the New Routine—Today

simplipro-box-new
Request a Test

References

*Based on multiple clinical trials in 1,605 patients, the SimpliPro Colon test has identified specific markers which have been found to correlate with the presence of colorectal cancer and advanced adenoma.

  1. Blume, John E., et al. The discovery and validation of blood plasma protein-based classifier panels for colorectal cancer and advanced adenoma using a combined mass spectrometry- and ELISA-based workflow in studies including 1,605 patient samples [abstract]. In: Digestive Disease Week; 2016 May 21-24; San Diego, CA. Oral presentation.

After you have typed in some text, hit ENTER to start searching...